All lobbying filings

BANNER PUBLIC AFFAIRS, LLC

Lobbying for THE CIGNA GROUP AND SUBSIDIARIES (FKA CIGNA CORPORATION AND SUBSIDIARIES) · Health Care Services

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $20,000.00 income · posted Jul 21, 2025

Official filing document

Bills named in this filing 11

HR 4016
Department of Defense Appropriations Act, 2026
HR 3838
Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 20…
S 2296
National Defense Authorization Act for Fiscal Year 2026
S 526
Pharmacy Benefit Manager Transparency Act of 2025
HR 2214
DRUG Act
S 1339
Pharmacy Benefit Manager Reform Act
S 1542
DRUG Act
S 1038
Drug Price Transparency in Medicaid Act of 2023
HR 1613
Drug Price Transparency in Medicaid Act of 2023
S 5503
PBM Act
HR 10362
PBM Act of 2024

Lobbying activity 2

Defense

Pharmacy issues related to TRICARE; H.R. 4016 - Department of Defense Appropriations, FY2026; H.R. 3838 - Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026; S. 2296 - National Defense Authorization Act for Fiscal Year 2026.

Health Issues

S.526 - Pharmacy Benefit Manager Transparency Act of 2025; S. 1339 - Pharmacy Benefit Reform Act (118th Congress); S. 1542/H.R. 2214 - DRUG Act (118th Congress); S. 1038/H.R. 1613 - Drug Price Transparency in Medicaid Act of 2023 (118th Congress); S. 5503/H.R. 10362 - PBM Act of 2024 (118th Congress).

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.